PH17715A - Elastase-containing composition permitting elastase to be absorbed in increased amount - Google Patents

Elastase-containing composition permitting elastase to be absorbed in increased amount

Info

Publication number
PH17715A
PH17715A PH26824A PH26824A PH17715A PH 17715 A PH17715 A PH 17715A PH 26824 A PH26824 A PH 26824A PH 26824 A PH26824 A PH 26824A PH 17715 A PH17715 A PH 17715A
Authority
PH
Philippines
Prior art keywords
elastase
absorbed
containing composition
increased amount
composition permitting
Prior art date
Application number
PH26824A
Other languages
English (en)
Inventor
Kazuo Taki
Kouichi Katayama
Ryoichi Machida
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH17715A publication Critical patent/PH17715A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH26824A 1981-02-03 1982-02-03 Elastase-containing composition permitting elastase to be absorbed in increased amount PH17715A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56013754A JPS57128634A (en) 1981-02-03 1981-02-03 Elastase-containing compound increasing absorption

Publications (1)

Publication Number Publication Date
PH17715A true PH17715A (en) 1984-11-19

Family

ID=11842034

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26824A PH17715A (en) 1981-02-03 1982-02-03 Elastase-containing composition permitting elastase to be absorbed in increased amount

Country Status (8)

Country Link
US (1) US4397951A (ja)
EP (1) EP0057462B1 (ja)
JP (1) JPS57128634A (ja)
KR (1) KR880001808B1 (ja)
CA (1) CA1182747A (ja)
DE (1) DE3260589D1 (ja)
ES (1) ES509221A0 (ja)
PH (1) PH17715A (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208236A (ja) * 1982-05-28 1983-12-03 Eisai Co Ltd 糖尿病性腎症治療剤
JPS5951221A (ja) * 1982-09-17 1984-03-24 Eisai Co Ltd 変形性関節症治療剤
JPS61191610A (ja) * 1985-02-20 1986-08-26 Dai Ichi Kogyo Seiyaku Co Ltd 胃液中で速やかに溶解する錠剤
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
JPS6485660A (en) * 1987-02-19 1989-03-30 Nippon Medical Supply Suture coated with sugar fatty acid ester
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
HU205010B (en) * 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
JPH02292226A (ja) * 1989-05-08 1990-12-03 Shigemi Fujisaki 障害された神経細胞賦活予防治療剤
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
KR100564021B1 (ko) * 2002-12-11 2006-03-24 주식회사종근당 극성 약물의 경구용 약제학적 조성물
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
US8642564B2 (en) * 2004-08-25 2014-02-04 Aegis Therapeutics, Llc Compositions for drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
EP2457580A1 (en) * 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US9114069B2 (en) * 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US20090258865A1 (en) * 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
ES2917973T3 (es) 2011-06-14 2022-07-12 Neurelis Inc Administración de benzodiacepina
CN105775051B (zh) * 2016-03-03 2017-08-11 上海船舶研究设计院 多功能油田增产作业支持船

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837444A (en) * 1956-10-26 1960-06-15 Armour & Co Improvements in and relating to the preparation of elastase
GB1076776A (en) * 1963-10-10 1967-07-19 Rolland Lab A Process for the extraction of elastase
GB1448276A (en) * 1973-09-15 1976-09-02 Eisai Co Ltd Elastase and methods for using same
JPS5261287A (en) * 1975-11-08 1977-05-20 Eisai Co Ltd Preparation of pancreatic elastase

Also Published As

Publication number Publication date
JPS57128634A (en) 1982-08-10
US4397951A (en) 1983-08-09
DE3260589D1 (en) 1984-09-27
KR830008681A (ko) 1983-12-14
ES8502334A1 (es) 1985-01-01
ES509221A0 (es) 1985-01-01
JPH0150686B2 (ja) 1989-10-31
EP0057462B1 (en) 1984-08-22
EP0057462A3 (en) 1982-12-29
CA1182747A (en) 1985-02-19
EP0057462A2 (en) 1982-08-11
KR880001808B1 (ko) 1988-09-19

Similar Documents

Publication Publication Date Title
DE3260589D1 (en) Elastase-containing composition permitting elastase to be absorbed in increased amount
GB2093132B (en) Improvements in or relating to loadlocks
GB2093701B (en) Improvements in or relating to bonegraft material
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
GB2098620B (en) Improvements in or relating to organic compounds
DE3279322D1 (en) Improvements in and relating to applicators
ZA787058B (en) Improvements in or relating to plansifters
GB2078522B (en) Improvements in and relating to sanitizing compositions
GB2100760B (en) Improvements in or relating to organic compounds
GB2109671B (en) Improvements in or relating to supports
GB2102780B (en) Improvements in or relating to compounds
DE3363813D1 (en) Improvements in and relating to substituted tetrahydrona phthalenes
GB2099693B (en) Improvements in or relating to castors
GB2094301B (en) Improvements in or relating to organic compounds
PT72477A (en) Improvements in or relating to amino-fibres
AU8300083A (en) Improvements in or relating to trailers
GB2100303B (en) Improvements in or relating to cardclothing
GB2096533B (en) Improvements in or relating to extrusion
GB2134577B (en) Improvements in or relating to roadsigns
GB2300318B (en) Improvements in or relating to transceivers
GB2109675B (en) Improvements in and relating to trestles
GB2107079B (en) Improvements in and relating to interferometers
GB2101773B (en) Improvements in and relating to heaters
PT74879A (en) Improvements in or relating to construction
GB2089135B (en) Improvements in or relating to baluns

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 11